Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Neuropharmacology. 2010 Jan 14;58(7):1002–1008. doi: 10.1016/j.neuropharm.2010.01.003

Figure 3.

Figure 3

Intact rats show no limb use asymmetry in the VSFP test at baseline (BL). The unilateral 6-OHDA lesion (LX) impairs contralateral performance, and this impairment is partially restored by chronic L-DOPA + vehicle for MK-801 (see 0 mg/kg). MK-801 dose-dependently prevents L-DOPA's therapeutic effects. * p < 0.05 relative to BL, # p < 0.05 relative to LX, + p < 0.05 relative to vehicle for MK-801 (0 mg/kg).